Envista (NYSE:NVST) Stock Rating Upgraded by Mizuho

Envista (NYSE:NVST) was upgraded by equities researchers at Mizuho from a “strong sell” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

Other analysts also recently issued research reports about the company. Stifel Nicolaus set a $25.00 price target on Envista in a research note on Thursday, October 30th. JPMorgan Chase & Co. lifted their price target on shares of Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, December 16th. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Barclays began coverage on shares of Envista in a research note on Monday, December 8th. They issued an “overweight” rating and a $24.00 target price on the stock. Finally, Evercore ISI reiterated an “outperform” rating on shares of Envista in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Envista has an average rating of “Hold” and a consensus price target of $22.15.

Envista Stock Down 3.6%

NVST stock opened at $24.33 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. Envista has a 12 month low of $14.22 and a 12 month high of $25.41. The firm has a market cap of $4.00 billion, a PE ratio of 270.31, a P/E/G ratio of 1.13 and a beta of 0.99. The firm has a 50 day simple moving average of $21.67 and a 200 day simple moving average of $20.85.

Envista (NYSE:NVST) last released its earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The firm’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period last year, the firm posted $0.12 earnings per share. Equities research analysts forecast that Envista will post 1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Holocene Advisors LP acquired a new position in Envista during the second quarter worth $43,936,000. Norges Bank acquired a new stake in shares of Envista in the second quarter valued at $40,229,000. Alliancebernstein L.P. raised its holdings in shares of Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after buying an additional 1,547,656 shares during the last quarter. Franklin Resources Inc. lifted its position in Envista by 16.7% during the 2nd quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock worth $175,011,000 after buying an additional 1,284,767 shares in the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in Envista during the 3rd quarter worth about $24,260,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.